Hansen Carl L. G. 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Purchase | 2023-12-31 | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 60,740,524 20.600% | 1,747,217 (+2.96%) | Filing |
| 2023-02-06 4:31 pm Purchase | 2022-12-31 | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 58,993,307 20.400% | 3,586,608 (+6.47%) | Filing |
| 2022-02-10 4:30 pm Sale | 2021-12-31 | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 55,406,699 19.500% | -6,421,131 (-10.39%) | Filing |
| 2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | AbCellera Biologics Inc. ABCL | Hansen Carl L. G. | 61,827,830 23.000% | 61,827,830 (New Position) | Filing |